CA Patent

CA2902987A1 — Benzyl-substituted pyrazolopyridines and use thereof

Assigned to Bayer Pharma AG · Expires 2014-09-04 · 12y expired

What this patent protects

The present invention relates to novel benzyl-substituted pyrazolopyridines, a method for producing them, their use alone or in combinations for treating and/or preventing diseases and their use for producing medicaments for treating and/or preventing diseases, in particular for …

USPTO Abstract

The present invention relates to novel benzyl-substituted pyrazolopyridines, a method for producing them, their use alone or in combinations for treating and/or preventing diseases and their use for producing medicaments for treating and/or preventing diseases, in particular for treating and/or preventing cardiovascular diseases.

Drugs covered by this patent

Patent Metadata

Patent number
CA2902987A1
Jurisdiction
CA
Classification
—
Expires
2014-09-04
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.